New paper for GemVax & KAEL Co., Ltd.

SEOUL, MARCH 29: GemVax & KAEL Co., Ltd. has announced that a paper on GV1001, a novel Alzheimer’s treatment based on telomerase modification, was published on March 26th in the SCI-grade international journal ‘Alzheimer’s Research & Therapy’. www.gemvax.com